[1] TZAHOR E,POSS K D.Cardiac regeneration strategies:staying young at heart[J].Sci,2017,356(6342):1035-1039.
[2] COLLET J P,THIELE H,BARBATO E,et al.2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J].Eur Heart J,2021,42(14):1289-1367.
[3] FEDEDA J P,GERLICH D W.Molecular control of animal cell cytokinesis[J].Nat Cell Biol,2012,14(5):440-447.
[4] MCALLISTER H A.Primary tumors and cysts of the heart and pericardium[J].Curr Probl Cardiol,1979,4(2):1-51.
[5] OBERPRILLER J O,OBERPRILLER J C.Response of the adult newt ventricle to injury[J].J Exp Zool,1974,187(2):249-253.
[6] POSS K D,WILSON L G,KEATING M T.Heart regeneration in zebrafish[J].Sci,2002,298(5601):2188-2190.
[7] ROBLEDO M.Myocardial regeneration in young rats[J].Am J Pathol,1956,32(6):1215-1239.
[8] PU W,ZHANG M,LIU X,et al.Genetic proliferation tracing reveals a rapid cell cycle withdrawal in preadolescent cardiomyocytes[J].Circulation,2022,145(5):410-412.
[9] LÁZÁR E,SADEK H A,BERGMANN O.Cardiomyocyte renewal in the human heart:insights from the fall-out[J].Eur Heart J,2017,38(30):2333-2342.
[10] MOLLOVA M,BERSELL K,WALSH S,et al.Cardiomyocyte proliferation contributes to heart growth in young humans[J].Proc Natl Acad Sci U S A,2013,110(4):1446-1451.
[11] MOHAMED T M A,ANG Y S,RADZINSKY E,et al.Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration[J].Cell,2018,173(1):104-116.e12.
[12] BERSELL K,ARAB S,HARING B,et al.Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury[J].Cell,2009,138(2):257-270.
[13] MAGADUM A,SINGH N,KURIAN A A,et al.Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration[J].Circulation,2020,141(15):1249-1265.
[14] VUJIC A,NATARAJAN N,LEE R T.Molecular mechanisms of heart regeneration[J].Semin Cell Dev Biol,2020,100:20-28.
[15] MOHAMED T M A,ABOULEISA R,HILL B G.Metabolic determinants of cardiomyocyte proliferation[J].Stem Cells,2022,40(5):458-467.
[16] KIM W,JHO E H.The history and regulatory mechanism of the Hippo pathway[J].BMB Rep,2018,51(3):106-118.
[17] DRISKILL J H,PAN D.The Hippo pathway in liver homeostasis and pathophysiology[J].Annu Rev Pathol,2021,16:299-322.
[18] FU M,HU Y,LAN T,et al.The Hippo signalling pathway and its implications in human health and diseases[J].Signal Transduct Target Ther,2022,7(1):376.
[19] WEI X,SHIMIZU T,LAI Z C.Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila[J].EMBO J,2007,26(7):1772-1781.
[20] PRASKOVA M,XIA F,AVRUCH J.MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation[J].Curr Biol,2008,18(5):311-321.
[21] ARDESTANI A,LUPSE B,MAEDLER K.Hippo signaling:key emerging pathway in cellular and whole-body metabolism[J].Trends Endocrinol Metab,2018,29(7):492-509.
[22] XU T,WANG W,ZHANG S,et al.Identifying tumor suppressors in genetic mosaics:the Drosophila lats gene encodes a putative protein kinase[J].Development,1995,121(4):1053-1063.
[23] SE R,Y F,CG H.Hippo-Yap/Taz signalling in zebrafish regeneration[J].NPJ Regen Med,2022,7(1):9.
[24] MENG F,XIE B,MARTIN J F.Targeting the Hippo pathway in heart repair[J].Cardiovasc Res,2022,118(11):2402-2414.
[25] HEALLEN T,MORIKAWA Y,LEACH J,et al.Hippo signaling impedes adult heart regeneration[J].Development,2013,140(23):4683-4690.
[26] FRANCISCO J,ZHANG Y,JEONG J I,et al.Blockade of fibroblast YAP attenuates cardiac fibrosis and dysfunction through MRTF-A inhibition[J].JACC Basic Transl Sci,2020,5(9):931-945.
[27] WANG J,LIU S,HEALLEN T,et al.The Hippo pathway in the heart:pivotal roles in development,disease,and regeneration[J].Nat Rev Cardiol,2018,15(11):672-684.
[28] LIU S,TANG L,ZHAO X,et al.Yap promotes noncanonical Wnt signals from cardiomyocytes for heart regeneration[J].Circ Res,2021,129(8):782-797.
[29] LI J,GAO E,VITE A,et al.Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity[J].Circ Res,2015,116(1):70-79.
[30] TIAN Y,LIU Y,WANG T,et al.A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice[J].Sci Transl Med,2015,7(279):279ra38.
[31] CITRI A,YARDEN Y.EGF-ERBB signalling:towards the systems level[J].Nat Rev Mol Cell Biol,2006,7(7):505-516.
[32] FERNANDEZ CUESTA L,THOMAS R K.Molecular pathways:targeting NRG1 fusions in lung cancer[J].Clin Cancer Res,2015,21(9):1989-1994.
[33] TROMBETTA D,ROSSI A,FABRIZIO F P,et al.NRG1-ErbB lost in translation:a new paradigm for lung cancer?[J].Curr Med Chem,2017,24(38):4213-4228.
[34] NAGASAKA M,OU S I.NRG1 and NRG2 fusion positive solid tumor malignancies:a paradigm of ligand-fusion oncogenesis[J].Trends Cancer,2022,8(3):242-258.
[35] KIVELÄ R,HEMANTHAKUMAR K A,VAPARANTA K,et al.Endothelial cells regulate physiological cardiomyocyte growth via VEGFR2-mediated paracrine signaling[J].Circulation,2019,139(22):2570-2584.
[36] VAPARANTA K,JOKILAMMI A,PAATERO I,et al.STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth[J].EMBO Rep,2023,24(5):e56689.
[37] GREGO BESSA J,GÓMEZ APIÑANIZ P,PRADOS B,et al.Nrg1 regulates cardiomyocyte migration and cell cycle in ventricular development[J].Circ Res,2023,133(11):927-943.
[38] GASSMANN M,CASAGRANDA F,ORIOLI D,et al.Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor[J].Nature,1995,378(6555):390-394.
[39] LEE K F,SIMON H,CHEN H,et al.Requirement for neuregulin receptor erbb2 in neural and cardiac development[J].Nature,1995,378(6555):394-398.
[40] LEMMENS K,DOGGEN K,DE KEULENAER G W.Activation of the neuregulin/erbb system during physiological ventricular remodeling in pregnancy[J].Am J Physiol Heart Circ Physiol,2011,300(3):H931-942.
[41] GEMBERLING M,KARRA R,DICKSON A L,et al.Nrg1 is an injury-induced cardiomyocyte mitogen for the endogenous heart regeneration program in zebrafish[J].Elife,2015,4:e05871.
[42] LIU X,GU X,LI Z,et al.Neuregulin-1/erbb-activation improves cardiac function and survival in models of ischemic,dilated,and viral cardiomyopathy[J].J Am Coll Cardiol,2006,48(7):1438-1447.
[43] KOMURO A,NAGAI M,NAVIN N E,et al.WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus[J].J Biol Chem,2003,278(35):33334-33341.
[44] HE C,LV X,HUA G,et al.YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression[J].Oncogene,2015,34(50):6040-6054.
[45] AHARONOV A,SHAKKED A,UMANSKY K B,et al.ERBB2 drives YAP activation and EMT-like processes during cardiac regeneration[J].Nat Cell Biol,2020,22(11):1346-1356.
[46] GALLO S,VITACOLONNA A,BONZANO A,et al.ERK:a key player in the pathophysiology of cardiac hypertrophy[J].Int J Mol Sci,2019,20(9):2164.
[47] GRIMES K M,MAILLET M,SWOBODA C O,et al.MEK1-ERK1/2 signaling regulates the cardiomyocyte non-sarcomeric actin cytoskeletal network[J].Am J Physiol Heart Circ Physiol,2024,326(1):H180-H189.
[48] WIDMANN C,GIBSON S,JARPE M B,et al.Mitogen-activated protein kinase:conservation of a three-kinase module from yeast to human[J].Physiol Rev,1999,79(1):143-180.
[49] LI X M,MA Y T,YANG Y N,et al.Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure[J].Clin Exp Pharmacol Physiol,2009,36(11):1054-1061.
[50] BUENO O F,DE WINDT L J,TYMITZ K M,et al.The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice[J].EMBO J,2000,19(23):6341-6350.
[51] LIU Z,CHEN J M,HUANG H,et al.The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway[J].Metabolism,2016,65(3):122-130.
[52] OTTANI A,GALANTUCCI M,ARDIMENTO E,et al.Modulation of the JAK/ERK/STAT signaling in melanocortin-induced inhibition of local and systemic responses to myocardial ischemia/reperfusion[J].Pharmacol Res,2013,72:1-8.
[53] LU Y G,TAN H,MA Q,et al.SH2 domain-containing protein tyrosine phosphatase-2(SHP-2) prevents cardiac remodeling after myocardial infarction through ERK/SMAD signaling pathway[J].Hum Cell,2021,34(2):325-334.
[54] EID R A,ALKHATEEB M A,AL SHRAIM M,et al.Ghrelin prevents cardiac cell apoptosis during cardiac remodelling post experimentally induced myocardial infarction in rats via activation of Raf-MEK1/2-ERK1/2 signalling[J].Arch Physiol Biochem,2019,125(2):93-103.
[55] VALIŠ K,NOVÁK P.Targeting ERK-Hippo interplay in cancer therapy[J].Int J Mol Sci,2020,21(9):3236.
[56] YOU B,YANG Y L,XU Z,et al.Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells[J].Oncotarget,2015,6(6):4357-4368.
[57] HAO X,SHI B,LI W,et al.Fasudil inhibits hepatic artery spasm by repressing the YAP/ERK/ ETA/ETB signaling pathway via inhibiting ROCK activation[J].Aging,2022,14(18):7378-7389.
[58] ZHANG Y,YUAN J,ZHANG X,et al.Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway[J].Oncol Rep,2016,36(6):3619-3626.
[59] YE L,HAIDER H K,JIANG S,et al.Angiopoietin-1 for myocardial angiogenesis:a comparison between delivery strategies[J].Eur J Heart Fail,2007,9(5):458-465.
[60] MANSOUR S G,BHATRAJU P K,COCA S G,et al.Angiopoietins as prognostic markers for future kidney disease and heart failure events after acute kidney injury[J].J Am Soc Nephrol,2022,33(3):613-627.
[61] SURI C,JONES P F,PATAN S,et al.Requisite role of angiopoietin-1,a ligand for the TIE2 receptor,during embryonic angiogenesis[J].Cell,1996,87(7):1171-1180.
[62] DALLABRIDA S M,ISMAIL N,OBERLE J R,et al.Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins[J].Circ Res,2005,96(4):e8-24.
[63] LEE S W,WON J Y,LEE H Y,et al.Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade[J].Mol Med,2011,17(9-10):1095-1106.
[64] YOUN S W,LEE H C,LEE S W,et al.COMP-angiopoietin-1 accelerates muscle regeneration through N-cadherin activation[J].Sci Rep,2018,8(1):12323.
[65] TAO Z,LOO S,SU L,et al.Angiopoietin-1 enhanced myocyte mitosis,engraftment,and the reparability of hiPSC-CMs for treatment of myocardial infarction[J].Cardiovasc Res,2021,117(6):1578-1591. |
